Scholars Central

Conference abstractPublished 18 Jul 2016

Personalized medicine for resistant cancer-a potential new role for herbal medicine.

Authors: Moses S S Chow

Western University of Health Sciences, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer is currently the number one killer of all diseases worldwide. One important factor for this high mortality is the development of chemotherapy resistance due to genetic heterogeneity and tumour physiology (environment). Despite advances in modern technique of developing new medicinal entities by targeting the mechanisms one site with one single drug at a time, such approach has not resulted in major impact of cancer mortality as of to date. Herbal medicine (HM) usually contains multiple components some of which can possess anticancer properties capable of targeting multiple mechanisms. Thus HM can offer a new opportunity to overcome drug resistance and/or improving efficacy, especially when combined with conventional anticancer agents and applied to individual patients via a personalized medicine approach. The steps required for successful implementation of combined herb-drug approach for personalized treatment of resistant cancer is challenging and will be presented and discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectOncology & Cancer
  • SubjectAlternative & Palliative Care
  • BylineArticles whose byline prints “Moses S S Chow”